111 related articles for article (PubMed ID: 24517028)
1. Effects of iron on the pharmacokinetics of paracetamol in saliva.
Issa MM; Nejem RM; Shanab AA
Pak J Biol Sci; 2013 Dec; 16(24):2050-3. PubMed ID: 24517028
[TBL] [Abstract][Full Text] [Related]
2. Oral ciprofloxacin affects the pharmacokinetics of paracetamol in saliva.
Issa MM; Nejem RM; El-Abadla NS
Clin Drug Investig; 2006; 26(4):223-6. PubMed ID: 17163255
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and saliva secretion of paracetamol in healthy male Nigerians.
Babalola CP; Oladimeji FA; Femi-Oyewo MN
West Afr J Med; 2004; 23(1):10-4. PubMed ID: 15171517
[TBL] [Abstract][Full Text] [Related]
4. Ferrous sulphate interacts with captopril.
Schaefer JP; Tam Y; Hasinoff BB; Tawfik S; Peng Y; Reimche L; Campbell NR
Br J Clin Pharmacol; 1998 Oct; 46(4):377-81. PubMed ID: 9803987
[TBL] [Abstract][Full Text] [Related]
5. Saliva vs. plasma bioequivalence of paracetamol in humans: validation of class I drugs of the salivary excretion classification system.
Idkaidek N; Arafat T
Drug Res (Stuttg); 2014 Oct; 64(10):559-62. PubMed ID: 24452519
[TBL] [Abstract][Full Text] [Related]
6. Effects of iron supplements on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in humans.
Stass H; Kubitza D
Clin Pharmacokinet; 2001; 40 Suppl 1():57-62. PubMed ID: 11352443
[TBL] [Abstract][Full Text] [Related]
7. Effects of paracetamol on the pharmacokinetics of ciprofloxacin in plasma using a microbiological assay.
Issa MM; Nejem RM; El-Abadla NS; El-Naby MK; Roshdy AA; Kheiralla ZA
Clin Drug Investig; 2007; 27(7):463-7. PubMed ID: 17563126
[TBL] [Abstract][Full Text] [Related]
8. The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model.
Chiew A; Day P; Salonikas C; Naidoo D; Graudins A; Thomas R
Emerg Med Australas; 2010 Dec; 22(6):548-55. PubMed ID: 21143403
[TBL] [Abstract][Full Text] [Related]
9. Effect of study protocol on the interactions between cimetidine and paracetamol in man.
Garba M; Odunola MT; Ahmed BH
Eur J Drug Metab Pharmacokinet; 1999; 24(2):159-62. PubMed ID: 10510744
[TBL] [Abstract][Full Text] [Related]
10. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry.
Gomez HF; McClafferty HH; Flory D; Brent J; Dart RC
Ann Emerg Med; 1997 Nov; 30(5):587-92. PubMed ID: 9360566
[TBL] [Abstract][Full Text] [Related]
11. A five way crossover human volunteer study to compare the pharmacokinetics of paracetamol following oral administration of two commercially available paracetamol tablets and three development tablets containing paracetamol in combination with sodium bicarbonate or calcium carbonate.
Grattan T; Hickman R; Darby-Dowman A; Hayward M; Boyce M; Warrington S
Eur J Pharm Biopharm; 2000 May; 49(3):225-9. PubMed ID: 10799813
[TBL] [Abstract][Full Text] [Related]
12. Influence of menstrual cycle on the pharmacokinetics of paracetamol through salivary compartment in healthy subjects.
Gugilla SR; Boinpally RR; Bolla SM; Devaraj R
Ther Drug Monit; 2002 Aug; 24(4):497-501. PubMed ID: 12142633
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of Panadol Extend and immediate-release paracetamol in a simulated overdose model.
Tan C; Graudins A
Emerg Med Australas; 2006 Aug; 18(4):398-403. PubMed ID: 16842311
[TBL] [Abstract][Full Text] [Related]
14. Importance of entero-salivary recirculation in paracetamol pharmacokinetics.
Schaiquevich P; Niselman A; Rubio M
Biopharm Drug Dispos; 2002 Sep; 23(6):245-9. PubMed ID: 12214325
[TBL] [Abstract][Full Text] [Related]
15. Alteration of oral salivary pharmacokinetics of paracetamol by an investigational anti-malarial phytomedicine, in healthy human volunteers.
Obodozie O; Mustapha K; Inyang U
Eur J Drug Metab Pharmacokinet; 2004; 29(3):193-7. PubMed ID: 15537171
[TBL] [Abstract][Full Text] [Related]
16. Temporal variations in paracetamol absorption and metabolism in man.
Kamali F; Fry JR; Bell GD
Xenobiotica; 1987 May; 17(5):635-41. PubMed ID: 3604267
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and Bioavailability of a Fixed-Dose Combination of Ibuprofen and Paracetamol after Intravenous and Oral Administration.
Atkinson HC; Stanescu I; Frampton C; Salem II; Beasley CP; Robson R
Clin Drug Investig; 2015 Oct; 35(10):625-32. PubMed ID: 26334726
[TBL] [Abstract][Full Text] [Related]
18. Systemic exposure of Paracetamol (acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats and in vitro model: risk of liver toxicity.
Pingili RB; Pawar AK; Challa SR
Drug Dev Ind Pharm; 2015; 41(11):1793-800. PubMed ID: 25678313
[TBL] [Abstract][Full Text] [Related]
19. A new rapidly absorbed paediatric paracetamol suspension. A six-way crossover pharmacokinetic study comparingthe rate and extent of paracetamol absorption from a new paracetamol suspension with two marketed paediatric formulations.
Smith S; Collaku A; Heaslip L; Yue Y; Starkey YY; Clarke G; Kronfeld N
Drug Dev Ind Pharm; 2012 Mar; 38(3):372-9. PubMed ID: 21961887
[TBL] [Abstract][Full Text] [Related]
20. Effects of ascorbic acid on interactions between ciprofloxacin and ferrous sulphate, sodium ferrous citrate or ferric pyrophosphate, in mice.
Motoya T; Miyashita M; Kawachi A; Yamada K
J Pharm Pharmacol; 2000 Apr; 52(4):397-401. PubMed ID: 10813549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
